Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Year-over-year book value per share growth
Percentile
P0
Near historical low
vs 5Y Ago
-8.8x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -551.18% |
| Q3 2025 | -89.93% |
| Q2 2025 | 2.35% |
| Q1 2025 | -42.70% |
| Q4 2024 | -26.01% |
| Q3 2024 | -25.81% |
| Q2 2024 | 200.12% |
| Q1 2024 | -50.99% |
| Q4 2023 | 667.22% |
| Q3 2023 | -75.68% |
| Q2 2023 | -41.92% |
| Q1 2023 | -37.64% |
| Q4 2022 | -24.92% |
| Q3 2022 | -30.99% |
| Q2 2022 | -15.36% |
| Q1 2022 | -14.85% |
| Q4 2021 | -2.19% |
| Q3 2021 | -4.34% |
| Q2 2021 | -8.50% |
| Q1 2021 | -11.97% |
| Q4 2020 | 62.63% |
| Q3 2020 | -5.32% |
| Q2 2020 | 10.38% |
| Q1 2020 | -7.13% |
| Q4 2019 | -10.26% |
| Q3 2019 | -11.58% |
| Q2 2019 | -14.48% |
| Q1 2019 | 38.74% |
| Q4 2018 | -8.78% |
| Q3 2018 | -6.81% |
| Q2 2018 | -5.90% |
| Q1 2018 | 68.93% |
| Q4 2017 | 3.28% |
| Q3 2017 | -15.13% |
| Q2 2017 | -13.13% |
| Q1 2017 | 0.45% |
| Q4 2016 | 0.83% |
| Q3 2016 | 1.34% |
| Q2 2016 | -9.51% |
| Q1 2016 | -8.01% |